Tenofovir‐Related Nephrotoxicity: Case Report and Review of the Literature
- 1 March 2004
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 24 (3) , 415-418
- https://doi.org/10.1592/phco.24.4.415.33182
Abstract
Tenofovir is a nucleotide reverse transcriptase inhibitor for treatment of human immunodeficiency virus (HIV) infection. Several cases of renal failure associated with tenofovir therapy recently have been reported. A 54‐year‐old man with HIV experienced decreasing renal function and Fanconi's syndrome secondary to tenofovir therapy. His condition gradually improved after discontinuation of the drug. The available medical literature for reported cases of tenofovir‐related nephrotoxicity indicates that this complication is apparently rare. However, our case report and literature review underscore the importance of monitoring renal function when treating patients with any nucleotide reverse transcriptase inhibitor.Keywords
This publication has 7 references indexed in Scilit:
- Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes InsipidusClinical Infectious Diseases, 2003
- Renal lesions in HIV-1-positive patient treated with tenofovirAIDS, 2003
- Drug-induced Fanconi's syndromeAmerican Journal of Kidney Diseases, 2003
- Rapid Communication: Acute Renal Failure Associated with Tenofovir: Evidence of Drug-Induced NephrotoxicityThe Lancet Healthy Longevity, 2002
- Fanconi syndrome and renal failure induced by tenofovir: A first case reportAmerican Journal of Kidney Diseases, 2002
- Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitorsAntiviral Research, 2001
- HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGSNucleosides, Nucleotides and Nucleic Acids, 2001